
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2015-09-21 | Michael K. Simpson(R-ID02) | house | Purchase | $1,001 - $15,000 |
No financial data available for FBT.
Company may not file with SEC or CIK is unresolved.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
JPMorgan analyst sees opportunities in healthcare and financials
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors
Q4 2025 Earnings: AI Disruption Vs. Traditional Fundamentals
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Biotech Could Be One of 2026’s Biggest Winners, and This ETF Is Perfectly Positioned
Inside the Recent Strength in Biotech ETFs